WEST PHARMACEUTICAL SERVICES, INC. Increase (Decrease) in Operating Capital
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Increase (Decrease) in Operating Capital of $188.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingCapital · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. increase (decrease) in operating capital for the quarter ending 2026-06-30 was $86.00M, a 1997.56% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. increase (decrease) in operating capital for the quarter ending 2026-03-31 was $102.90M.
- WEST PHARMACEUTICAL SERVICES, INC. increase (decrease) in operating capital for the quarter ending 2025-09-30 was -$2.10M, a 2200.00% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. increase (decrease) in operating capital for the quarter ending 2025-06-30 was $4.10M.
| Period end | Increase (Decrease) in Operating Capital 3 month | Increase (Decrease) in Operating Capital 6 month | Increase (Decrease) in Operating Capital 9 month |
|---|---|---|---|
| 2026-06-30 | $86.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $188.90M 10-Q · filed 2026-07-23 | |
| 2026-03-31 | $102.90M 10-Q · filed 2026-04-23 | ||
| 2025-09-30 | -$2.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $2.00M derived: sum of 2 quarters · filed 2026-07-23 | $1.90M 10-Q · filed 2025-10-23 |
| 2025-06-30 | $4.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $4.00M 10-Q · filed 2026-07-23 | |
| 2025-03-31 | -$100.00K 10-Q · filed 2026-04-23 | ||
| 2024-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | -$14.00M derived: sum of 2 quarters · filed 2025-10-23 | $20.60M 10-Q · filed 2025-10-23 |
| 2024-06-30 | -$14.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-24 | $20.50M 10-Q · filed 2025-07-24 | |
| 2024-03-31 | $34.60M 10-Q · filed 2025-04-24 | ||
| 2023-09-30 | -$24.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | $47.30M 10-Q · filed 2024-10-24 | |
| 2023-06-30 | $72.10M 10-Q · filed 2024-07-25 | ||
| 2011-09-30 | -$5.40M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-07 | $27.30M 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $32.70M 10-Q/A · filed 2011-08-08 | ||
| 2010-09-30 | -$11.60M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-07 | $23.30M 10-Q · filed 2011-11-07 | |
| 2010-06-30 | $34.90M 10-Q/A · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |